We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.

CSL NORMAL IMMUNOGLOBULIN VF (human) 800mg/5mL injection vial (61216)

ARTG ID 61216

ARTG Name

CSL NORMAL IMMUNOGLOBULIN VF (human) 800mg/5mL injection vial

Product name

CSL NORMAL IMMUNOGLOBULIN VF (human) 800mg/5mL injection vial

ARTG Date

21 October 1998

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

normal immunoglobulin

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

CSL NORMAL IMMUNOGLOBULIN VF (human) 800 mg/5 mL injection vial, CSL Behring (Australia) Pty Ltd, CON-1164

15 September 2023

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 15 September 2023 until 1 October 2031. (the sunset date of TGO 108).
CSL NORMAL IMMUNOGLOBULIN VF (human) 800 mg/5 mL injection vial, CSL Behring Australia Pty Ltd, CON-1223

26 March 2024

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 26 March 2024 until 1 October 2031.
CSL NORMAL IMMUNOGLOBULIN VF (human) 800mg/5mL injection vial, CSL Behring Australia Pty Ltd, CON-1340

21 March 2025

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 21 March 2025 until 1 October 2031.
CSL NORMAL IMMUNOGLOBULIN VF (human) 800mg/5mL injection vial, CSL Behring Australia Pty Ltd, CON-1341

21 March 2025

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 21 March 2025 until 1 October 2031.
CSL NORMAL IMMUNOGLOBULIN VF (human) 800mg/5mL injection vial, CSL Behring, CON-1249

5 April 2024

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 5 April 2024 until 1 October 2031.

Is there anything wrong with this page?

Help us improve